{
  "pmcid": "10027760",
  "sha256": "c4d8425320bf0e224692f3835605b5cf2321719c141429d00da83b9a8ca5b4d3",
  "timestamp_utc": "2025-11-09T23:03:34.890982+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.049464285714286,
    "reading_ease": 19.270535714285728,
    "word_count": 224
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Indocyanine Green and Technetium Nanocolloid for Sentinel Lymph Node Detection in Pediatric Cancer"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "15 pediatric patients were prospectively included"
      },
      "Participants": {
        "score": 2,
        "evidence": "15 pediatric patients were prospectively included based on specific eligibility criteria. Conducted at UMC Utrecht"
      },
      "Intervention": {
        "score": 2,
        "evidence": "Preoperative ICG–TC injections were administered"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study investigates the feasibility of using indocyanine green (ICG) combined with 99m technetium nanocolloid (ICG–TC) for sentinel lymph node (SLN) detection in pediatric patients"
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was the intraoperative detection rate of SLNs"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "15 pediatric patients were prospectively included"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "SLNs were transcutaneously visible in 10/15 (67%) patients"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "SLNs were transcutaneously visible in 10/15 (67%) patients. Intraoperatively, 35/37 (95%) SLNs were fluorescent, and 37/37 (100%) were radioactive"
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NL71166.041.20"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified"
      }
    },
    "total_score": 14,
    "max_score": 25
  }
}